Nanomedicine News

RSS

Rapid Synthesis of Nanoscale Reporter Tags Offers Promising Alternative to Fluorescent Labeling

Visualizing the complex internal cellular processes within our bodies requires the use of photostable, optically active probes that can be tracked with special microscopy instruments. One technique, surface-enhanced Rama...

26 May 2010

Researchers Test C6-Ceramide Nanoliposomes on Cancer Cells

A new way to deliver cancer-fighting drugs using tiny particles made from lipids and chemotherapy drugs may have the power to knock out malignancies with a one-two punch. The strategy holds promise for patients with...

26 May 2010

Scaffold Gradients: Finding the Right Environment for Developing Cells

Now a research team from the National Institute of Standards and Technology (NIST) and the National Institutes of Health (NIH) has developed a way to offer cells a three-dimensional scaffold that varies over a broad range of degrees of stiffness to determine where they develop best.

From National Institute of Standards and Tech (NIST) 25 May 2010

NIH Senior Investigator Presents at Institute of Biophysics

Dr. Joshua Zimmerberg, senior investigator of the National Institutes of Health, USA visited the Institute of Biophysics (IBP) and delivered a lecture at the invitation of IBP director Professor XU Tao on May 20, 2010. ...

25 May 2010

Ablynx, Pfizer Extend Research Collaboration on Anti-TNF-Alpha Nanobodies

Ablynx (Euronext Brussels: ABLX) announced today that the research collaboration which forms part of its license agreement for Nanobodies to tumour necrosis factor alpha (TNF-alpha) with Pfizer has been extended for anot...

25 May 2010

Boehringer Ingelheim Selects Nanobody Candidate to Advance Therapies for Alzheimer's Disease

Ablynx [Euronext Brussels: ABLX] today announced that Boehringer Ingelheim has selected a Nanobody lead candidate for further development for the treatment of Alzheimer's disease. This is the first lead candidate ...

25 May 2010

Agilent Unveils New HPLC-Chip for N-Glycan Analysis

Agilent Technologies Inc. today introduced a new HPLC-Chip to address N-glycan analysis in the emerging biopharmaceutical market.

From Agilent Technologies Inc. 25 May 2010

Clinical Study Demonstrates Targeted Nanoparticle Delivery in Tumor Sites

Epeius Biotechnologies Corporation today announces the clinical results of the study entitled "A Phase I/II Study of Intravenous Rexin-G and Reximmune-C for Cancer Immunotherapy: The GeneVieve Protocol" at t...

25 May 2010

Shrink Nanotechnologies Files Patent Applications for StemDisc Tool

Shrink Nanotechnologies, Inc. (“Shrink”), an innovative nanotechnology company developing products and licensing opportunities in the solar energy production, medical diagnostics and sensors, and biotechnology research and development tools businesses, announced today that patent applications for its stem cell research and drug discovery tool StemDisc™ have been filed.

24 May 2010

Silica Particles Packed with Anti-Cancer Drugs Prevent Tumor Growth

Packaging anti-cancer drugs into particles of chemically modified silica improve the drugs' ability to fight skin cancer in mice, according to new research.

24 May 2010